Comprehensive Response to Fentanyl-Related Substances and Fentanyl-Laced Substances Act
- Last Action
- 5/26/2023
Actions
- 2023-05-26Referred to the Subcommittee on Health.
- 2023-05-23Sponsor introductory remarks on measure. (CR H2520)
- 2023-05-22Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-22Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-22Sponsor introductory remarks on measure. (CR H2486)
- 2023-05-22Introduced in House
- 2023-05-22Introduced in House
CRS Summary
As of 2023-05-22 (00)
Comprehensive Response to Fentanyl-Related Substances and Fentanyl-Laced Substances Act
This bill establishes several programs and requirements to address the use of fentanyl and fentanyl-laced substances.
For example, the bill expands the Comprehensive Opioid Abuse Grant Program in the Department of Justice (DOJ) to include training and resources for teachers on how to carry and administer opioid overdose reversal drugs (e.g., naloxone). DOJ must also increase resources and establish an interagency task force for law enforcement agencies to combat the trafficking of fentanyl-laced substances.
Additionally, the Department of Health and Human Services must develop a national strategy to prevent the use of fentanyl-laced substances, award grants to state and localities for treatment programs for those who are addicted to fentanyl-laced substances, and research the health effects of fentanyl-laced substances.
The bill also increases criminal penalties for adulterating or misbranding drugs if the violation results in serious bodily injury or death (imprisonment of up to 10 years, a fine of up to $1 million, or both for violations that result in serious bodily injury, and up to life imprisonment, a fine of up to $5 million, or both for violations that result in death). Penalties are higher for violations that include the intent to defraud or mislead. The bill adds up to 5 years of additional imprisonment if the violation involves drugs that are promoted or sold online.
Cosponsors (7)
- Yvette Clarke (D-NY)
- Joyce Beatty (D-OH)
- Gwen Moore (D-WI)
- Steven Horsford (D-NV)
- Jonathan Jackson (D-IL)
- Sheila Cherfilus-McCormick (D-FL)
- Donald Payne (D-NJ)
Subjects
- Civil actions and liability
- Criminal procedure and sentencing
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Elementary and secondary education
- Health promotion and preventive care
- Higher education
- Intergovernmental relations
- Law enforcement administration and funding
- Medical research
- Smuggling and trafficking
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.